Atrial Fibrillation (AF) is the most common heart rhythm disorder. It affects between 900,000 and 1.5 million people in France and can increase by 5 the risk of developing a stroke. Awareness of this disease on June 10, 2022.
The Nancy CHRU Heart Rhythmology Team, accompanied by Biosense Webster, a leader in the diagnosis and treatment of heart rhythm disorders, organizes on Friday, June 10, 2022 on the St Sébastien square in Nancyan unprecedented awareness event to take your heart to heart.
Atrial Fibrillation, a common disease
Atrial Fibrillation, also called AF, affects 1 in 40 people over the age of 40. This heart rhythm disorder speeds up the heart and causes it to beat irregularly. AF is often related to age, but also to obesity or sleep apnea. Unrecognized, the pathology is usually reduced to its most dreaded risk: stroke, the leading cause of physical disability in adults in France.
Asymptomatic for some patients, others will experience heart palpitations, abnormal shortness of breath or unusual fatigue, which will severely impact their daily lives and require medical attention.
Multi-stage support at Nancy CHRU
At Nancy CHRU’s Heart Rhythmology Department, more than 3,000 patients with AF are treated each year with nearly 500 curative interventions. “Patients are usually treated with anticoagulants, thus preventing strokes,” says Dr. Jean-Marc Sellal, a cardiologist at the CHRU in Nancy. “When the symptoms of AF are too disabling (shortness of breath, palpitations, chest pain), we perform a curative treatment, catheter ablation. It is a minimally invasive procedure that involves neutralizing the areas responsible for the pathology within the heart tissue, and more specifically in the left atrium ”.
The doctor also states that catheter ablation can provide a cure for 80% of beginner forms and 60% of advanced forms. The management of this pathology takes place in several stages at the CHRU: “We first carry out a screening with the loan of equipment compatible with a smartphone,” continues Dr. JeanMarc Sellal. “Then anticoagulant treatment is put in place, followed by treatment of symptoms that can lead to intra-cardiac procedures such as ablation.”
An unprecedented campaign for the general public and health professionals
Screening is essential to treat AF, prevent complications, and reduce symptoms.
The “Know All About AF” bus carried by the Nancy CHRU Heart Rhythmology Team, the Heart Association and Biosense Webster stops in Nancy. Friday, June 10, 2022, small square San Sebastian to raise awareness and inform patients and the general public about heart rhythm disorders and cardiovascular risks.
Aboard the double decker bus, Visitors will be able to learn about the symptoms and risk factors associated with this disease, the treatment options, but also get tips on how to better manage this disease that affects the quality of life of many patients. Discussion spaces will be hosted by the CHRU care teams and the association’s nurses. Visitors will also be able to check their heart rate, blood pressure and blood sugar in dedicated screening areas.
Information for cardiologists, June 9, 2022
Information from healthcare professionals involved in diagnosing and addressing patients is also important to avoid late referral of patients with a high risk of stroke.
That’s why a dedicated information evening to city cardiologists will take place on Thursday, June 9, 2022, Faivre amphitheater, Louis Mathieu building in Brabois ; the opportunity to strengthen the multidisciplinary coordination between the different medical specialties and to take stock of the management techniques developed at the CHRU for this disease.
About the Heart Alliance
The “Alliance du Cœur” Association, an association approved by the Ministry of Health, has the mission of informing, supporting, showing solidarity and supporting people with cardiovascular diseases and their relatives. The association contributes to the promotion of health and the primary and secondary prevention of heart and blood vessel diseases and participates in the representation of users of the health system with French and international health institutions and the various actors in the health system. health. www.alliancecoeur.fr
About Biosense Webster
Biosense Webster, Inc. is a world leader in the science of the diagnosis and treatment of heart rhythm disorders. Biosense Webster has partnered with clinicians to develop innovative technologies that improve the quality of care for arrhythmia patients around the world. Biosense Webster is part of Johnson & Johnson MedTech